Earnings

Celldex Therapeutics (NASDAQ: CLDX) shares fell 8% after the company announced that its Phase 2 study evaluating subcutaneous barzolvolimab in prurigo nodularis, a chronic inflammatory skin condition, failed to meet both its primary and secondary endpoints. The result marks a significant setback for one …

Alaska Air Group (NYSE: ALK) slid 4% after issuing a disappointing near-term earnings outlook that overshadowed a better-than-expected second-quarter result. The carrier reported Q2 adjusted earnings per share of negative $0.92, slightly ahead of the negative $0.98 consensus estimate, on revenue of $4.07 billion, …

Forestar Group Inc. posted earnings per share of $0.70 for the quarter ended June 30, 2026, shy of the $0.82 consensus forecast. The miss prompted an immediate 3.9% slide, valuing the stock at $27.11 in the latest session.

General Motors delivered a quarter that underscored the resilience of U.S. consumer demand, reporting $48 billion in revenue and a 43% surge in North America profits. The results sent a signal to investors that pricing power in the auto sector remains intact, even as …

KeyCorp’s second-quarter results delivered a profit surge and margin expansion, but investors sent shares lower as the regional bank’s performance lagged larger rivals. Revenue climbed 7% to $1.96 billion, fueled by a 9% increase in net interest income, while the net interest margin ticked …

Park Aerospace Corp. Net sales for the period were $18,312,000, an increase from $15,400,000 recorded a year earlier. Adjusted EBITDA reached $4,576,000, reflecting operational improvements over the prior year’s figures.

The market reacted to GM’s earnings release with the stock moving lower during the trading session, reflecting investor assessment of the updated outlook.